Prevention and Lipid Lowering Therapy in Acute Coronary Syndromes

ARMYDA-ACS: Atorvastatin for Reduction of Myocardial Damage During Angioplasty - Acute Coronary Syndromes Trial

      -Atorvastatin Pretreatment Improves Outcome in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention by Dr. Germano Di Sciascio (2007)


YELLOW: Reduction in Yellow Plaque by Aggressive Lipid Lowering Therapy

      -Trial Overview by Dr. Annapoorna Kini (ACC 2012)


Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at For further information please see the Policy section. Webmaster